Table of Contents
Journal of Allergy
Volume 2009 (2009), Article ID 821013, 3 pages
http://dx.doi.org/10.1155/2009/821013
Case Report

Treatment with Mycophenolat Mofetil of Steroid-Dependent Asthma—One Case of Severe Asthma

1Department of Respiratory Medicine, Copenhagen University Hospital, Bispebjerg Hospital, DK-2400 Copenhagen, Denmark
2Department of Dermatology, Copenhagen University Hospital, Bispebjerg Hospital, DK-2400 Copenhagen, Denmark

Received 2 March 2009; Revised 18 July 2009; Accepted 9 September 2009

Academic Editor: Massimo Triggiani

Copyright © 2009 V. Backer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Pacheco-Galván, “Refractory asthma: the ongoing debate,” Archivos de Bronconeumologia, vol. 42, no. 4, pp. 157–159, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. Global Initiative for Asthma (GINA), “The Global Strategy for the Diagnosis and Management of Asthma in Children 5 Years and Younger,” 2006, http://www.ginasthma.org/.
  3. S. T. Holgate and R. Polosa, “Treatment strategies for allergy and asthma,” Nature Reviews Immunology, vol. 8, no. 3, pp. 218–230, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Polosa and J. Morjaria, “Immunomodulatory and biologic therapies for severe refractory asthma,” Respiratory Medicine, vol. 102, no. 11, pp. 1499–1510, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Yamagata and M. Ichinose, “Agents against cytokine synthesis or receptors,” European Journal of Pharmacology, vol. 533, no. 1–3, pp. 289–301, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. P. M. O'Byrne, “Cytokines or their antagonist for the treatment of asthma,” Chest, vol. 130, no. 1, pp. 244–250, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Powell, S. Till, J. Bungre, and C. Corrigan, “The immunomodulatory drugs cyclosporin A, mycophenolate mofetil, and sirolimus (rapamycin) inhibit allergen-induced proliferation and IL-5 production by PBMCs from atopic asthmatic patients,” Journal of Allergy and Clinical Immunology, vol. 108, no. 6, pp. 915–917, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. C. J. Corrigan, J. K. Bungre, B. Assoufi, A. E. Cooper, H. Seddon, and A. B. Kay, “Glucocorticoid resistant asthma: T-lymphocyte steroid metabolism and sensitivity to glucocorticoids and immunosuppressive agents,” European Respiratory Journal, vol. 9, no. 10, pp. 2077–2086, 1996. View at Google Scholar · View at Scopus
  9. A. C. Allison and E. M. Eugui, “Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection,” Transplantation, vol. 80, supplement 2, pp. S181–S190, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. A. C. Allison and E. M. Eugui, “Mycophenolate mofetil and its mechanisms of action,” Immunopharmacology, vol. 47, no. 2-3, pp. 85–118, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Morath and M. Zeier, “Review of the antiproliferative properties of mycophenolate mofetil in non-immune cells,” International Journal of Clinical Pharmacology and Therapeutics, vol. 41, no. 10, pp. 465–469, 2003. View at Google Scholar · View at Scopus